Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Open Forum Infectious Diseases|January 20, 2022
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare WorkersSi'Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
The Journal of Infectious Diseases|October 21, 2021
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months PostinfectionZhongyan Lu, Eric D Laing, Jarina Pena DaMata, et al.
BMC Infectious Diseases|June 10, 2021
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workersBelinda M Jackson-Thompson, Emilie Goguet, Eric D Laing, et al.
JAMA Network Open|January 18, 2023
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 InfectionStephanie A Richard, Simon D Pollett, Anthony C Fries, et al.
Open Forum Infectious Diseases|December 22, 2023
Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort StudyStephanie A Richard, Ann I Scher, Jennifer Rusiecki, et al.
Emerging Infectious Diseases|February 24, 2022
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare WorkersEric D Laing, Carol D Weiss, Emily C Samuels, et al.
Open Forum Infectious Diseases|February 24, 2022
Prospective Assessment of Symptoms to Evaluate Asymptomatic SARS-CoV-2 Infections in a Cohort of Health Care WorkersEmilie Goguet, John H Powers, Cara H Olsen, et al.
The Journal of Infectious Diseases|June 25, 2024
Precision symptom phenotyping identifies early clinical and proteomic predictors of distinct COVID-19 sequelaeNusrat J Epsi, Josh G Chenoweth, Paul W Blair, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Stephanie A Richard, David A Lindholm, et al.
The New England Journal of Medicine|May 24, 2020
Remdesivir for the Treatment of Covid-19 - Final ReportJohn H Beigel, Kay M Tomashek, Lori E Dodd, et al.
Pageof 10